ciprofloxacin has been researched along with cefoperazone in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.69) | 18.7374 |
| 1990's | 12 (30.77) | 18.2507 |
| 2000's | 13 (33.33) | 29.6817 |
| 2010's | 10 (25.64) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, HA; Beskid, G; Christenson, JG; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Rossman, PL; Wei, CC | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Wei, CC | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Kwon, DH; Lu, CD | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Grime, K; Paine, SW | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ciebieda, I; Denys, A; Ferszt, T; Korczak, E | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Strauss, M | 1 |
| Breitenbucher, RB | 1 |
| Bodey, GP; Elting, L; Ho, DH | 1 |
| Marks, MI; Parker, KM; Stutman, HR | 1 |
| Boscia, JA; Kaye, D; Kobasa, WD | 1 |
| Cavallo, JD; Chevalier, B; Meyran, M | 1 |
| Kahn, JB; Peterson, LR; Ristow, TA | 1 |
| Chang, JC; Ho, SW; Hsieh, WC; Hsueh, PR; Luh, KT; Wu, JJ | 1 |
| Blondeau, JM; Suter, M; Vaughan, D; Yaschuk, Y | 1 |
| Mayer, I; Nagy, E | 1 |
| Jiang, L; Peng, Q; Yao, Y | 1 |
| Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Bindu, M; Kumar, G; Vengamma, B | 1 |
| An, MM; Cai, Y; Fang, Y; Liang, BB; Wang, R | 1 |
| Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
| Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y | 1 |
| Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
| Abay, S; Akar, M; Aydin, F; Balkan Bozlak, CE; Baykal, A; Buyuk, E; Buyuk, F; Celebi, O; Celik, E; Coskun, MR; Durhan, S; Ersoy, Y; Gulmez Saglam, A; Karakaya, E; Kayman, T; Otlu, S; Sahin, M; Saticioglu, IB | 1 |
1 review(s) available for ciprofloxacin and cefoperazone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
38 other study(ies) available for ciprofloxacin and cefoperazone
| Article | Year |
|---|---|
Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Mice; Pseudomonas aeruginosa; Spectrophotometry, Infrared; Staphylococcus aureus; Streptococcus pneumoniae | 1991 |
Dual-action cephalosporins incorporating a 3'-tertiary-amine-linked quinolone.
Topics: beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitrogen; Quinolines; Structure-Activity Relationship | 1994 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts | 1992 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
Current therapy of malignant external otitis.
Topics: Aged; Cefoperazone; Ceftazidime; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Otitis Externa; Pseudomonas Infections | 1990 |
UTI: managing the most common nursing home infection.
Topics: Activities of Daily Living; Aged; Cefoperazone; Ciprofloxacin; Cross Infection; Female; Homes for the Aged; Humans; Hygiene; Male; Nursing Homes; Prevalence; Risk Factors; Sex Factors; Urinary Catheterization; Urinary Tract Infections | 1990 |
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins | 1988 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Enterobacter; Enterobacteriaceae Infections; Female; Fluoroquinolones; Naphthyridines; Rabbits | 1987 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
Topics: Anti-Infective Agents; Cefoperazone; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Therapy, Combination; Kinetics; Microbial Sensitivity Tests; Ofloxacin; Time Factors; Xanthomonas | 1995 |
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Diffusion; Flavobacterium; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Piperacillin | 1997 |
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Haemophilus; Humans; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moraxella; Pseudomonas; Respiratory Tract Infections; Staphylococcus; Streptococcus; Ticarcillin; Urinary Tract Infections | 1999 |
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas | 1999 |
[Penetration of ciprofloxacin and cefoperazone into human pancreas].
Topics: Adult; Ampulla of Vater; Anti-Infective Agents; Cefoperazone; Cephalosporins; Ciprofloxacin; Common Bile Duct Neoplasms; Humans; Middle Aged; Pancreas; Pancreatic Juice; Pancreatitis | 1997 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
Anthrax meningoencephalitis successfully treated.
Topics: Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Brain Edema; Cefoperazone; Cerebrospinal Fluid; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Male; Meningoencephalitis; Tomography, X-Ray Computed; Treatment Outcome; Unconsciousness | 2007 |
In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefoperazone; Ciprofloxacin; Disulfides; Drug Combinations; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulfinic Acids; Tobramycin | 2008 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam | 2014 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Cattle; Cefoperazone; Ciprofloxacin; Doxycycline; Gentamicins; Humans; Mammals; Microbial Sensitivity Tests; Rifampin; Sheep; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |